Major Pharmaceuticals: Levothyroxine Sodium Tablets, Usp, 50 Mcg (0.050 Mg), 10 Tablets (10 X 1) Unit Dose Blisters Per Carton
Recall Summary Major Pharmaceuticals is recalling Levothyroxine Sodium Tablets 50 mcg in unit dose blisters nationwide because the tablets contain less active ingredient than they should. Levothyroxine is a thyroid hormone replacement medication, and subpotent doses may not provide adequate treatment. The recall affects products distributed across all U.S. states and the District of Columbia.
- Recalling firm
- Major Pharmaceuticals
- Product
- Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3559-0; NDC Blister: 0904-6950-61
- Reason
- Subpotent Drug
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-07-13
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide in the USA.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/b550e114-73f9-4fe2-a449-baad843b8f26